1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Endometriosis-Pipeline Insights, 2017

Endometriosis-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “ Endometriosis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Endometriosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Endometriosis. DelveInsight’s Report also assesses the Endometriosis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Endometriosis
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Endometriosis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Endometriosis and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Endometriosis-Pipeline Insights, 2017
Illustrative

- Endometriosis Overview
- Endometriosis Pipeline Therapeutics
- Endometriosis Therapeutics under Development by Companies
- Endometriosis Filed and Phase III Products
- Comparative Analysis
- Endometriosis Phase II Products
- Comparative Analysis
- Endometriosis Phase I and IND Filed Products
- Comparative Analysis
- Endometriosis Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Endometriosis - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Endometriosis - Discontinued Products
- Endometriosis - Dormant Products
- Companies Involved in Therapeutics Development for Endometriosis
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Endometriosis, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Endometriosis Assessment by Monotherapy Products
- Endometriosis Assessment by Combination Products
- Endometriosis Assessment by Route of Administration
- Endometriosis Assessment by Stage and Route of Administration
- Endometriosis Assessment by Molecule Type
- Endometriosis Assessment by Stage and Molecule Type
- Endometriosis Therapeutics - Discontinued Products
- Endometriosis Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Endometriosis, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Endometriosis Assessment by Monotherapy Products
- Endometriosis Assessment by Combination Products
- Endometriosis Assessment by Route of Administration
- Endometriosis Assessment by Stage and Route of Administration
- Endometriosis Assessment by Molecule Type
- Endometriosis Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025 Summary Endometriosis is an estrogen-dependent, chronic, inflammatory disease characterized by the appearance and growth of ...

Cervical Dysplasia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Cervical Dysplasia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Global Cervical Dysplasia Market: Scope and Methodology This report on the global cervical dysplasia market analyzes the current and future prospects of the market. The report comprises an elaborate executive ...

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Endometriosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.